Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Prescient Therapeutics Limited (AU: PTX)

 
PTX Technical Analysis
5
As on 20th Dec 2024 PTX STOCK Price closed @ 0.04 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.06 & Strong Sell for SHORT-TERM with Stoploss of 0.07 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

PTXSTOCK Price

Open 0.04 Change Price %
High 0.04 1 Day 0.00 0.00
Low 0.04 1 Week 0.00 0.00
Close 0.04 1 Month 0.00 0.00
Volume 80119 1 Year -0.04 -50.00
52 Week High 0.10 | 52 Week Low 0.04
 
AU Australia Most Active Stocks
EVN 4.82 0.00%
SYA 0.03 50.00%
MSB 2.42 -20.66%
RSG 0.40 0.00%
TMG 0.04 0.00%
TLS 3.98 0.25%
MGR 1.89 -1.56%
PLS 2.07 -2.82%
SGR 0.19 -5.00%
LOT 0.18 0.00%
 
AU Australia Top Gainers Stocks
SCN 0.02 100.00%
SCN 0.02 100.00%
APV 0.02 100.00%
AGD 0.03 50.00%
AGD 0.03 50.00%
SCI 0.03 50.00%
SCI 0.03 50.00%
SCI 0.03 50.00%
SCI 0.03 50.00%
SCI 0.03 50.00%
 
AU Australia Top Losers Stocks
SRI 0.01 -50.00%
SRI 0.01 -50.00%
SRI 0.01 -50.00%
SRI 0.01 -50.00%
SRI 0.01 -50.00%
SRI 0.01 -50.00%
SRI 0.01 -50.00%
SRZ 0.01 -50.00%
CXZ 0.02 -33.33%
MAY 0.02 -33.33%
 
 
PTX
Daily Charts		 PTX
Intraday Charts		 Whats New @
Bazaartrend		 PTX
Free Analysis
 
PTX Important Levels Intraday
RESISTANCE0.04
RESISTANCE0.04
RESISTANCE0.04
RESISTANCE0.04
RESISTANCE0.04
RESISTANCE0.04
RESISTANCE0.04
RESISTANCE0.04
 
PTX Forecast December 2024
Share
4th UP Forecast0.08
3rd UP Forecast0.07
2nd UP Forecast0.06
1st UP Forecast0.05
1st DOWN Forecast0.03
2nd DOWN Forecast0.02
3rd DOWN Forecast0.01
4th DOWN Forecast0
 
PTX Weekly Forecast
4th UP Forecast0.06
3rd UP Forecast0.05
2nd UP Forecast0.05
1st UP Forecast0.05
1st DOWN Forecast0.03
2nd DOWN Forecast0.03
3rd DOWN Forecast0.03
4th DOWN Forecast0.02
 
PTX Forecast2024
4th UP Forecast0.16
3rd UP Forecast0.12
2nd UP Forecast0.1
1st UP Forecast0.07
1st DOWN Forecast0.01
2nd DOWN Forecast-0.02
3rd DOWN Forecast-0.04
4th DOWN Forecast-0.08
 
 
PTX Other Details
Segment EQ
Market Capital 170816592.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
PTX Address
PTX
 
PTX Latest News
 
Your Comments and Response on Prescient Therapeutics Limited
 
PTX Business Profile
Prescient Therapeutics Limited, a clinical stage oncology company, develops novel drugs for the treatment of various cancers in Australia. Its lead drug candidate is PTX-200, which is in Phase II clinical trial for HER2-negative breast cancer, Phase IB/2 clinical trial in relapsed and refractory AML, and Phase 1b in recurrent or persistent platinum-resistant ovarian cancer; and PTX-100, a RhoA inhibitor, for hematological and solid malignancies that focuses on cancers with Ras and RhoA mutations. Prescient Therapeutics Limited has a collaboration agreement with Carina Biotech to develop cell therapies. The company was formerly known as Virax Holdings Limited and changed its name to Prescient Therapeutics Limited in December 2014. Prescient Therapeutics Limited was incorporated in 1986 and is based in Melbourne, Australia. Address: 100 Albert Road, Melbourne, VIC, Australia, 3205
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service